Literature DB >> 8972640

Chronic low-dose UVA irradiation induces local suppression of contact hypersensitivity, Langerhans cell depletion and suppressor cell activation in C3H/HeJ mice.

R Bestak1, G M Halliday.   

Abstract

It has previously been demonstrated that chronic low-dose solar-simulated UV radiation could induce both local and systemic immunosuppression as well as tolerance to a topically applied hapten. In this study, we have used a chronic low-dose UV-irradiation protocol to investigate the effects of UVA on the skin immune system of C3H/ HeJ mice. Irradiation with UVA + B significantly suppressed the local and systemic primary contact hypersensitivity (CHS) response to the hapten 2,4,6-trinitrochlorobenzene. Furthermore UVA + B reduced Langerhans cell (LC) and dendritic epidermal T cell (DETC) densities in chronically UV-irradiated mice. Ultraviolet A irradiation induced local, but not systemic, immunosuppression and reduced LC (32%) but not DETC from the epidermis compared to the shaved control animals. Treatment of mice with both UVA + B and UVA radiation also induced an impaired secondary CHS response, and this tolerance was transferable with spleen cells. These results suggest that depletion of LC, but not DETC, may be involved in UVA-induced local immunosuppression in our model, and that tolerance was induced in the presence of normal numbers of DETC. Hence exposure of C3H/HeJ mice 5 days per week for 4 weeks with UVA can induce local immunosuppression and tolerance.

Entities:  

Mesh:

Year:  1996        PMID: 8972640     DOI: 10.1111/j.1751-1097.1996.tb01863.x

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  6 in total

1.  Heme oxygenase induction mediates the photoimmunoprotective activity of UVA radiation in the mouse.

Authors:  V E Reeve; R M Tyrrell
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

2.  Carcinogenesis related to intense pulsed light and UV exposure: an experimental animal study.

Authors:  L Hedelund; C Lerche; H C Wulf; M Haedersdal
Journal:  Lasers Med Sci       Date:  2006-09-09       Impact factor: 3.161

3.  Latest approved therapies for metastatic melanoma: what comes next?

Authors:  Farid Menaa
Journal:  J Skin Cancer       Date:  2013-02-24

Review 4.  Current management and novel agents for malignant melanoma.

Authors:  Byung Lee; Nikhil Mukhi; Delong Liu
Journal:  J Hematol Oncol       Date:  2012-02-14       Impact factor: 17.388

5.  Diversity of biological effects induced by longwave UVA rays (UVA1) in reconstructed skin.

Authors:  Claire Marionnet; Cécile Pierrard; Christelle Golebiewski; Françoise Bernerd
Journal:  PLoS One       Date:  2014-08-20       Impact factor: 3.240

Review 6.  UVA Radiation, DNA Damage, and Melanoma.

Authors:  Seung-Gi Jin; Francisco Padron; Gerd P Pfeifer
Journal:  ACS Omega       Date:  2022-09-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.